eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Bausch+Lomb - Comment

Bausch+Lomb - Comment

Document ID: FDA-2010-D-0319-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 11 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 18 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: November 12 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: 
Tracking Number: 80bc8727
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Bausch+Lomb - Comment

Title:
Bausch+Lomb - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 16
Sunovion Pharmaceuticals Inc. - Comment
Public Submission    Posted: 01/18/2011     ID: FDA-2010-D-0319-0005

Novo Nordisk Inc. - Comment
Public Submission    Posted: 01/18/2011     ID: FDA-2010-D-0319-0006

Bausch+Lomb - Comment
Public Submission    Posted: 01/18/2011     ID: FDA-2010-D-0319-0007

sanofi-aventis - Comment
Public Submission    Posted: 01/18/2011     ID: FDA-2010-D-0319-0009

American College of Cardiology - Comment
Public Submission    Posted: 01/18/2011     ID: FDA-2010-D-0319-0010